Nanotechnology RSS feeds

ENJOY THE BENEFITS

Simply Register to GAIN ACCESS to lots more info

USER LOGIN


copyright-Nanovip 2008

NANO FACTS

...Nanometres...
nanotechnology companies | nanotechnology info Human hair 80,000 nm wide
nanotechnology companies | nanotechnology info Red blood cell 7,000 nm wide
nanotechnology companies | nanotechnology info Water molecule 0.3 nm wide
nanotechnology companies | nanotechnology info Sheet Paper 100,000 nm wide

LATEST MEMBERS

  • lisa richards
  • tokmik
  • PamelSMIT
  • pramodl
  • rrichter
  • nanovipstaff

WHO'S ONLINE

There are currently 0 users and 10 guests online.

  Valid XHTML 1.0 Transitional

Button for your site

The Aurora Funds, Inc.


Address: 2525 Meridian Parkway, Suite 220
Zip: 27713

Visit this link

Phone :
(919) 484-0400

Fax :
(919) 484-0444

The Aurora Funds is a venture capital firm that provides capital, connections and strategic guidance to entrepreneurs with early-stage life sciences and information technology companies. Founded in 1994, Aurora manages over $155 million in four venture funds. The firm’s six investment professionals have over 100 years of combined venture capital investing and operational experience. The Aurora team has managed investments in over 50 companies, resulting in five IPOs and eight M&A transactions to date.

Aurora typically is a lead or co-lead investor in seed and early-stage financing opportunities located primarily in the Southeastern and mid-Atlantic United States. The firm’s initial investment size ranges from $50,000 in a seed investment to as much as $2.5 million in a first round financing. Aurora has the capacity to invest a total of between $4 million and $8 million across multiple rounds of financing as the company matures.

The firm has a balanced investment focus across both life sciences and information technology industries.

» | Edit this entry
                                                                                                                                                                                                                                                                                          
Back to previous page Go to the top of this page